Selection Sourcing Structure Standardization Safety Substantiation

Slides:



Advertisements
Similar presentations
WHY PHARMANEX.
Advertisements

Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
Pharmanex leading the health revolution MISSION n Help people achieve healthier more productive lives THE HEALING POWER OF KNOWLEDGE u Best reputation.
The EHPM Quality Guide: A template for best practice 10 December 2014 Michel Horn EHPM Quality Working Group.
Product Training Series
Variation Management of Key Characteristics
GeneriKairos® making faster Generics. Molecule patent expiry date Later expiring patents - Need significant R&D, might delay generic drug development.
UNITED SPINAL ASSOCIATION AUGUST, 2014 Biologics & Biosimilars: An Overview 1.
Dynamic Systems Development Method (DSDM)
What is a Generic Medication?. The World Health Organization Definition of a Generic Medication A generic drug is a pharmaceutical product, usually intended.
1 Certification Chapter 14, Storey. 2 Topics  What is certification?  Various forms of certification  The process of system certification (the planning.
The Application of the Scientific Method: Preclinical Trials Copyright PEER.tamu.edu.
Quality control of raw materials In-process control
+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.
Herbal Products Presented by Janice Hermann, PhD, RD/LD
Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development.
UNIT 3.04 Career Opportunities By PresenterMedia.comPresenterMedia.com.
Personnel Basic Principles of GMP Workshop on
AND GENERIC DRUGS BRAND-NAME AND GENERIC DRUGS WHAT TO CHOOSE? Natalia VEZIKOVA, MD, PhD, Natalia VEZIKOVA, MD, PhD, MSc The Head of the Hospital Therapy.
GLOBAL REGULATORY STRATEGY CONSIDERATIONS SCIENTIFIC SARAH POWELL EXECUTIVE DIRECTOR, REGULATORY STRATEGIES SEPTEMBER 14-17, 2008 BOSTON, MA.
Stages of drug development
The BIM Project Execution Planning Procedure
Regulatory Procedure for the Assessment of GM Foods.
What is an Inventory Program for? Dr. Emilio Moceo Ph.D Director of Studies Meet international obligations and expectations Inform international, national,
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication A substance used in the diagnosis, treatment,
CRITICAL APPRAISAL OF SCIENTIFIC LITERATURE
C-059-I0 EVET C-061-I0 DVEFVMPVLM A-041-N0 B-004-H0 AORTA D-115-G0 C-068-I0 UP- DMHTE.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Dietary Supplements. Definition by DSHEA Product that is to supplement a healthy diet. Includes ingredients such as vitamins, minerals, herbs, botanicals,
Chapter 6 CRISIS MANAGEMENT. Introduction - Crisis: ◦is a situation that specifically involves a pharmaceutical product, medical device or activity with.
Important informations
Presented by Becky Cox Director, Pharmanex Marketing
” Building Research Centre “AgroBioTech“ Demand-oriented project ITMS code:
Case Study SummaryChallenges Cisco WebEx, the world market leader in online web conference, has been working with Link Translation since 2009 to support.
The Pharmaceutical Industry and International Clinical Research: One Company’s Approach Michael Clayman, M.D. Vice President, Lilly Research Laboratories.
WHO Workshop on Prequalification of Medicines Programme, Abu Dhabi, October, 2010 Regulatory principles reflected in practice of WHO PQP Milan Smid,
Nutraceuticals & New Dietary Ingredients The Swiss Perspective Willi Hunziker, DVM, MBA
Molecule-to-Market-Place Quality
Copyright© Underwriters Laboratories Inc. All rights reserved. No portion of this material may be reprinted in any form without the express written.
The New Drug Development Process (www. fda. gov/cder/handbook/develop
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
6S Quality Process.
Design Documentation Clint Kehres, Brian Krouse, Jenn Shafner.
General Regulatory Issues in the Development of Drugs Intended for Treatment of Chronic Illness Sharon Hertz, M.D. Medical Officer Division of Anesthetic,
Preparation for FDA Advisory Committee Meetings Robert M. Kirsch, RAC Vice President, Regulatory Affairs TolerRx Inc. Cambridge, MA.
ITFG/IPAC Collaboration CMC Supplier Quality Control Technical Team ITFG/IPAC TECHNICAL TEAM: SUPPLIER QUALITY CONTROL (QUALIFICATION) Presented by: Gordon.
Are you really getting your money’s worth when buying health supplements as such as Ginkgo biloba?
ANLEC R&D COMMUNICATION PACK ( ). Trace emissions from Oxy Combustions do not pose significantly higher health, environmental or operational.
OVER THE COUNTER MEDS INTRODUCTION No prescriptions are necessary and no questions need to be answered to attain these drugs OTC med use saves.
CM&C Inspections The Pre-Approval Inspection (PAI) in the US 27 May 2010.
ITFG/IPAC Collaboration CMC Leachables and Extractables Technical Team ITFG/IPAC TECHNICAL TEAM: CMC LEACHABLES AND EXTRACTABLES Presented by: Kaushik.
Chapter 1: The Nature of Analytical Chemistry
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
NUTRITION: HERBAL SUPPLEMENTS- EFFICACY & SAFETY by Dominique Hall Biology 1310 Professor Lang.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication recognized or defined by the U.S. Food, Drug,
Lean Lab and Cost Reduction
Product Information File or PIF
Software Quality Assurance
Biotechnology R&D.
The Many Careers of Pharmacy
Making a Difference! is not an official Shaklee® publication.
Clinical Engineering Lecture (3).
Agenda Who are we? 1 Introductions Journey so far 2
Scientific Inquiry Standard B – 1.7.
Lesson 8 Good Production Practice #8
Pharmaceuticals Industry
Generic vs Name Brand Drugs
The British Retail Consortium (BRC)
Permit to Work Coordinator Middlesbrough, UK
Presentation transcript:

Selection Sourcing Structure Standardization Safety Substantiation 6S Quality Process Selection Sourcing Structure Standardization Safety Substantiation At Nu Skin, we use proprietary technology in our manufacturing processes to maintain tight quality controls through all stages of product development. The key to consistent quality is the Pharmanex® 6S Quality Process, the basis of the company's pharmaceutical approach to product development. This process involves a complex set of highly integrated activities that ensures that every Pharmanex product is absolutely safe and effective.

Selection To locate the botanicals with the most effective health-promoting properties, Nu Skin employs teams of experts from the United States and Asia. These teams conduct exhaustive research— compiling, reviewing, and summarizing historical use and current intelligence about a botanical's properties and health benefits. Nu Skin also conducts original research to identify new botanicals, coordinating with noted professionals from around the world. Only botanicals that pass extensive tests for authenticity, usefulness, and safety are considered for use in our Pharmanex products.

Sourcing Once Nu Skin decides to proceed with a particular botanical, a team investigates potential sources of the botanical and conducts exhaustive analyses on samples from each source. Sources may be domestic or international and may include Pharmanex cultivation areas in China and Chile. Nu Skin chooses a supplier based on the quality and concentration level of the active ingredient(s) present in samples from that source.

Structure Using state-of-the-art analytical techniques and working in collaboration with respected universities and laboratories in both China and the United States, Nu Skin conducts structural analyses of the natural compounds present in the selected botanical. These analyses isolate and purify specific chemical structures in standardized extracts, a critical step in ensuring a safe and effective botanical.

Standardization Wide variations in active ingredients are characteristic of any botanical. For example, when Nu Skin analyzes potential Ginkgo biloba leaves, studies reveal the concentrations of active components will vary by as much as 300 percent depending on season, climate, soil, method of harvest, storage conditions, and processing. Nu Skin optimizes the active ingredients of a product through strict, proprietary standardization processes (to at least one relevant marker molecule). Each capsule of a Pharmanex® product contains the same amount of each active ingredient.

Safety Nu Skin is leading the way in establishing strict standards to ensure the safety of its Pharmanex products. Scientists research and document the history of a product's use and safety. Pharmaceutical-grade tests for the presence of microbes, toxins, and heavy metals are carried out for all products. The active ingredient amount used is based on dosages found effective through clinical trials and is backed by published data on file at Nu Skin. Each product label contains directions for use and contains appropriate warning information.

Substantiation Nu Skin only makes Pharmanex product claims that have been substantiated through documented preclinical and clinical studies. Existing clinical data are reviewed, and when necessary, Nu Skin sponsors studies of its products. Data from some of these studies are subsequently submitted to major international journals for review. This adherence to scientific standards for substantiation helps make Nu Skin's Pharmanex brand a leader in the natural healthcare product industry. The attention to detail, strict scientific testing, and commitment to quality ensures that every Pharmanex® product is absolutely safe and effective. The 6S® Quality Process has enabled Nu Skin to become an industry leader in quality and efficacy.